CD44 and familial pancreatic carcinoma: In pancreatic cancer, a recent study by Rasheed et al. demonstrated increased tumorigenic potential of ALDHhigh/CD44+/CD24+ and CD44+/CD24+ pancreatic cancer cell populations with ALDH expression correlating with a worse prognosis in early stage pancreatic cancer patients [17].